DNM1L and diabetes mellitus: In parallel with reduced atherosclerosis, reductions in mitochondrial fragmentation, oxidative stress, endothelial dysfunction, and inflammation were observed, thereby providing evidence to support the premise that targeting mitochondrial fission and DRP1 in diabetes might be of benefit for atherosclerosis [66].